首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1764873

2031 年北美器官保存解決方案市場預測 - 區域分析 - 按產品、應用、類型和最終用戶

North America Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User

出版日期: 2025年04月17日 | 出版商:

The Insight Partners | 英文 140 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023 年北美器官保存液市場價值為 1,23,239.05 千美元，預計到 2031 年將達到 2,26,118.82 千美元；預計 2024 年至 2031 年的複合年成長率為 8.0%。

器官移植需求不斷成長，推動北美器官保存解決方案市場

已知有多種慢性疾病會損害心臟、肺、肝、腎和其他器官的功能。不良飲食會導致腎臟和肝臟疾病，進而導致器官衰竭。例如，全球約有 10% 的人口患有慢性腎臟病。根據美國衛生與公共服務部的數據，估計美國超過七分之一（即約 15% 或約 3.7 萬名成年人）患有慢性腎臟病。此外，過量飲酒會導致肝硬化，因此需要進行肝臟移植。移植接受者科學登記處 (SRTR) 報告稱，無論心臟衰竭的藥物治療是否成功，符合新心臟移植條件的候選人數量都在持續增加。 COVID-19 疫情對新登記名單產生了一定影響。在 2018 年至 2020 年保持平穩，2020 年略有下降（從 2019 年的 4,087 例下降到 2020 年的 4,000 例）之後，2021 年新發心臟衰竭病例數增加到 4,373 例。移植手術在世界各地變得越來越普遍。 2023 年，器官共享聯合網路報告稱，美國進行了超過 46,000 例器官移植，比 2022 年成長了 8.7% 以上。此外，美國歷史上首次進行了 27,000 例腎臟移植。等待器官移植的患者通常患有末期器官疾病，這會嚴重影響他們的生活品質，並可能表明他們已接近生命的終點。末期器官衰竭患者數量的增加引發了及時器官移植的需求。由於移植技術的進步，更多這樣的人現在有資格接受器官移植。器官保存液用於在一定時期內維持器官的活力和功能，以便將其運輸並隨後移植到接受者體內。器官移植的成功主要取決於器官保存、手術、免疫治療和術後照護。因此，器官移植需求的不斷成長推動了器官保存液市場的成長。

北美器官保存解決方案市場概覽

北美器官保存解決方案市場細分為美國、加拿大和墨西哥。技術先進產品和解決方案的日益普及，以及器官移植數量的激增，是該地區器官保存解決方案市場的受益因素。美國是全球最大的器官保存解決方案市場，預計在預測期內將佔據全球市場的主導地位。美國市場的成長歸因於美國慢性腎臟病 (CKD) 盛行率的上升和老年人口的增加。根據美國國家慢性腎臟病說明書，2021 年美國約有 3.7 萬人患有慢性腎臟病。

2024 年 6 月，美國腎臟基金會報告稱，多達 3.7 萬美國人患有腎臟疾病，約 80.8 萬美國人受到腎衰竭的影響。超過 55.7 萬美國人正在接受透析治療。腎臟疾病的盛行率正在上升，目前影響到超過七分之一（或 14%）的美國成年人。 2021 年，約有 13.5 萬美國人被新診斷出患有腎衰竭。此外，十分之九的腎臟疾病患者並不知道自己患有腎臟疾病，三分之一的腎功能嚴重下降的患者也不知道自己患有腎臟疾病。此外，根據同一消息來源，超過 25 萬美國人接受了腎臟移植，超過 9.3 萬美國人在腎臟移植等候名單上。 2023 年，只有 27,332 人接受了腎臟移植，其中 6,290 人來自活體捐贈者。美國食品藥物管理局 (FDA) 批准數量的增加以及市場參與者的存在推動了美國器官保存解決方案市場的成長。 2022 年 4 月，TransMedics Group, Inc. 宣布其 OCS 心臟系統已獲得 FDA 上市前批准，該系統可用於循環死亡 (DCD) 後捐贈者的器官。 OCS 心臟系統已被批准用於體外復活、功能監測和循環死亡 (DCD) 後捐贈心臟的跳動保存。因此，器官移植需求的增加推動了美國器官保存解決方案市場的發展。美國的器官保存解決方案製造商推出用於器官運輸的設備。 2023 年 8 月，領先的器官移植公司 Paragonix Technologies 的下一代供肺保存系統 BAROguard 獲得了 FDA 批准。該系統將 Paragonix 先進的低溫保存技術與自動持續主動式氣道壓力控制相結合。這確保了捐贈者肺部從捐贈者到接受者的整個過程中，始終保持最佳溫度範圍和臨床建議的充氣壓力範圍。這種新穎的先進技術組合強化了公司持續致力於改進和重新定義移植醫學護理標準的承諾。

北美器官保存解決方案市場收入及預測（2031 年）（千美元）

北美器官保存解決方案市場細分

北美器官保存解決方案市場分為產品、應用、類型、最終用戶和國家。

根據產品類型，北美器官保存液市場分為威斯康辛大學溶液、custodiol HTK、Perfadex、HypoThermosol 等。威斯康辛大學溶液在2023年佔據了最大的市場佔有率。

從應用角度來看，北美器官保存液市場細分為靜態冷藏、低溫機械灌注、常溫機械灌注等。靜態冷藏領域在2023年佔據了最大的市場。

依類型分類，北美器官保存液市場分為腎臟、肝臟、肺臟、心臟和其他器官。腎臟器官在2023年佔據了最大的市場。

根據最終用戶，北美器官保存解決方案市場細分為器官移植中心、醫院和專科診所。器官移植中心在2023年佔據了最大的市場。

依國家分類，北美器官保存液市場分為美國、加拿大和墨西哥。 2023年，美國佔據了北美器官保存液市場的主導地位。

Waters Medical Systems LLC、XVIVO Perfusion、TransMedics、OrganOx Limited、Paragonix Technologies, Inc、Dr. Franz Koehler Chemie GmbH、Accord Healthcare、21ST Century Medicine 和 Bridge to Life Ltd. 是北美器官保存解決方案市場領先的公司。

Several chronic diseases are known to damage the functioning of the heart, lungs, liver, kidney, and other organs. A poor diet contributes to the development of renal and hepatic illnesses, which can also lead to organ failure. For instance, around 10% of the global population is impacted by chronic kidney disease. According to the US Department of Health & Human Services, more than 1 in 7 (i.e., ~15% or ~37 thousand adults) are estimated to have chronic kidney disease in the US. Further, excessive alcohol consumption leads to liver cirrhosis, resulting in the need for a liver transplant. The Scientific Registry of Transplant Recipients (SRTR) reports that irrespective of the success of medical treatments for heart failure, the number of candidates eligible for new heart transplants continues to rise. The COVID-19 pandemic had some impact on new listings. After a plateau from 2018 through 2020 and a slight decrease in 2020 (from 4,087 in 2019 to 4,000 in 2020), the number of new heart failure cases increased to 4,373 in 2021. Transplantation surgeries are becoming more common worldwide. In 2023, the United Network for Organ Sharing reported a record of more than 46,000 organ transplants in the US, marking an increase of over 8.7% from 2022. Additionally, the country crossed the mark of 27,000 kidney transplants for the first time in its history. Patients who are on the organ waiting list typically suffer from end-stage organ disease, which significantly affects their quality of life and may indicate that they are nearing the end of their life. The rising number of individuals with end-stage organ failure triggers the need for timely organ transplantation. Due to advancements in transplantation techniques, more such people are now eligible for organ transplants. Organ preservation solutions are used to maintain the viability and function of organs for a certain period, allowing for their transport and subsequent transplantation into a recipient. The success of organ transplantation is primarily determined by organ preservation, surgery, immunotherapy, and post-operative care. Thus, a rising demand for organ transplantation drives the organ preservation solution market toward growth.

North America Organ Preservation Solution Market Overview

The North America organ preservation solution market is segmented into the US, Canada, and Mexico. Increasing adoption of technologically advanced products and solutions, and surging number of organ transplants are the factors benefiting the organ preservation solution market in this region. The US is the largest organ preservation solution market across the world and is estimated to dominate the global market during the forecast period. The US market growth is attributed to the rising chronic kidney diseases (CKD) prevalence and the increasing geriatric population in the US. According to the National Chronic Kidney Disease fact sheet, ~37 thousand people in the US were suffering from chronic kidney diseases in 2021.

In June 2024, the American Kidney Fund, Inc. reported that up to 37 thousand Americans have kidney disease, and ~808,000 Americans are affected by kidney failure. More than 557,000 Americans are undergoing dialysis treatment. The prevalence of kidney disease is rising and currently affects over 1 in 7 (or 14%) of American adults. In 2021, around 135,000 Americans were newly diagnosed with kidney failure. Also, 9 out of 10 people affected by kidney disease are unaware they have it, and 1 in 3 of people with severely reduced kidney function are also unaware they have kidney disease. Furthermore, as per the same source stated that more than 250,000 Americans have undergone kidney transplants, and there are over 93,000 Americans on the kidney transplant waiting list. In 2023, only 27,332 people received kidney transplants, with 6,290 of those from living donors. The rising number of approvals from the US Food and Drug Administration (FDA) and the presence of market players in the country boost the US organ preservation solution market growth. In April 2022, TransMedics Group, Inc. announced that it received premarket FDA approval for its OCS Heart System, which can be used with organs from donors after circulatory death (DCD). The OCS Heart System is approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death (DCD) hearts. Thus, the rising need for organ transplantation drives the organ preservation solutions market in the US. Organ preservation solution manufacturers in the US launch devices used for organ transportation. In August 2023, Paragonix Technologies, a leading organ transplant company, received FDA clearance for its next-generation donor lung preservation system, BAROguard. The system combines Paragonix's advanced hypothermic preservation technology with automated continuous and active airway pressure control. This ensures that an optimal temperature range and a clinically recommended inflation pressure range for donor lungs are maintained throughout the journey from the donor to the recipient patient. This novel combination of advanced technologies reinforces the company's ongoing commitment to improving and redefining the standard of care within transplant medicine.

North America Organ Preservation Solution Market Revenue and Forecast to 2031 (US$ Thousand)

North America Organ Preservation Solution Market Segmentation

The North America organ preservation solution market is categorized into product, application, type, end user, and country.

Based on product, the North America organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, HypoThermosol, and others. The University of Wisconsin segment held the largest market share in 2023.

In terms of application, the North America organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest market share in 2023.

By type, the North America organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest market share in 2023.

Based on end user, the North America organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest market share in 2023.

By country, the North America organ preservation solution market is segmented into the US, Canada, and Mexico. The US dominated the North America organ preservation solution market share in 2023.

Waters Medical Systems LLC, XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST Century Medicine, and Bridge to Life Ltd., are among the leading companies operating in the North America organ preservation solution market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Organ Preservation Solution Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Need for Organ Transplantation
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 Expensive Organ Transplant Surgeries
- 4.2.2 Limited Organ Availability
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Shift Toward Machine Perfusion Technique
4.5 Impact of Drivers and Restraints:

5. Organ Preservation Solution Market - North America Analysis

5.1 Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
5.2 Organ Preservation Solution Market forecast Analysis

6. North America Organ Preservation Solution Market Analysis - by Product

6.1 University of Wisconsin Solution
- 6.1.1 Overview
- 6.1.2 University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.2 Custodiol HTK
- 6.2.1 Overview
- 6.2.2 Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.3 Perfadex
- 6.3.1 Overview
- 6.3.2 Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.4 HypoThermosol
- 6.4.1 Overview
- 6.4.2 HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.5 Others
- 6.5.1 Overview
- 6.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

7. North America Organ Preservation Solution Market Analysis - by Application

7.1 Static Cold Storage
- 7.1.1 Overview
- 7.1.2 Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.2 Hypothermic Machine Perfusion
- 7.2.1 Overview
- 7.2.2 Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.3 Normothermic Machine Perfusion
- 7.3.1 Overview
- 7.3.2 Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

8. North America Organ Preservation Solution Market Analysis - by Type

8.1 Kidneys
- 8.1.1 Overview
- 8.1.2 Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.2 Liver
- 8.2.1 Overview
- 8.2.2 Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.3 Lungs
- 8.3.1 Overview
- 8.3.2 Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.4 Heart
- 8.4.1 Overview
- 8.4.2 Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

9. North America Organ Preservation Solution Market Analysis - by End User

9.1 Organ Transplant Centers
- 9.1.1 Overview
- 9.1.2 Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
9.2 Hospitals
- 9.2.1 Overview
- 9.2.2 Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

10. North America Organ Preservation Solution Market - Country Analysis

10.1 North America Organ Preservation Solution Market Overview
- 10.1.1 North America: Organ Preservation Solution Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 10.1.1.1 North America: Organ Preservation Solution Market - Revenue and forecast Analysis - by Country
  - 10.1.1.2 United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.2.1 United States: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.2.2 United States: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.2.3 United States: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.2.4 United States: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.3 Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.3.1 Canada: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.3.2 Canada: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.3.3 Canada: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.3.4 Canada: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.4 Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.4.1 Mexico: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.4.2 Mexico: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.4.3 Mexico: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.4.4 Mexico: Organ Preservation Solution Market Breakdown, by End User

11. Organ Preservation Solutions Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in Organ Preservation Solutions Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Waters Medical Systems LLC
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 XVIVO Perfusion
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 TransMedics
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 OrganOx Limited
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Paragonix Technologies, Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dr. Franz Koehler Chemie GmbH
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Accord Healthcare
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8st Century Medicine
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Bridge to Life Ltd
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Organ Preservation Solution Market Segmentation
Table 2. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Table 3. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 4. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 5. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 6. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 7. North America: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Country
Table 8. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 9. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 10. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 11. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 12. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 13. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 14. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 15. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 16. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 17. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 18. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 19. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 20. Recent Organic Growth Strategies in Organ Preservation Solutions Market
Table 21. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
Table 22. Glossary of Terms, Organ Preservation Solution Market

List Of Figures

Figure 1. North America Organ Preservation Solution Market Segmentation, by Country
Figure 2. Organ Preservation Solution Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
Figure 5. Organ Preservation Solution Market Share (%) - by Product (2023 and 2031)
Figure 6. University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 7. Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 8. Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 9. HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 10. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 11. Organ Preservation Solution Market Share (%) - by Application (2023 and 2031)
Figure 12. Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 13. Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 14. Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 15. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 16. Organ Preservation Solution Market Share (%) - by Type (2023 and 2031)
Figure 17. Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 18. Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 19. Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 20. Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 21. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 22. Organ Preservation Solution Market Share (%) - by End User (2023 and 2031)
Figure 23. Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 24. Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 25. Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 26. North America Organ Preservation Solution Market, by Key Country - Revenue (2023) (US$ Thousand)
Figure 27. North America: Organ Preservation Solution Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 28. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 29. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 30. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 31. Growth Strategies in Organ Preservation Solutions Market